or Try an Advanced Search...

    Type I Hypersensitivity Stocks List

    Symbol Grade Name % Change
    ARQT B Arcutis Biotherapeutics, Inc. 0.00
    FBRX B Forte Biosciences, Inc. 0.00
    SPRY C ARS Pharmaceuticals, Inc. 0.00
    THRD D Third Harmonic Bio, Inc. 0.00
    HOTH F Hoth Therapeutics, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Atopic Dermatitis Atopy Dermatitis Immunology Medicine Allergy Dermatology Eczema Organ Systems Sodium Hypochlorite Washes Allergology Alopecia Areata Anaphylaxis Autoimmune Disease Biopharmaceutical Chronic Urticaria Dermatological Diseases Disease Healing Immunoglobulin E

    Related ETFs - A few ETFs which own one or more of the above listed Type I Hypersensitivity stocks.

    Symbol Grade Name Weight
    PTH D Invesco DWA Healthcare Momentum ETF 1.05
    SBIO C ALPS Medical Breakthroughs ETF 0.88
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.86
    XBI D SPDR S&P Biotech ETF 0.6
    LABU F Direxion Daily S&P Biotech Bull 3X Shares 0.38
    View all Type I Hypersensitivity ETFs...
    Compare ETFs
    Compare PTH to LABU Compare SBIO to BBC Compare SBIO to LABU

        Type I Hypersensitivity Stocks Recent News

        Date Stock Title
        Nov 20 FBRX Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
        Nov 20 SPRY ARS Pharmaceuticals: Demand Curve Is Key Unknown
        Nov 20 ARQT Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 200-Day Moving Average
        Nov 20 ARQT Arcutis Biotherapeutics, Inc. (ARQT) Crossed Above the 50-Day Moving Average: What That Means for Investors
        Nov 20 FBRX Forte Biosciences announces oversubscribed $53 million private placement
        Nov 20 FBRX Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
        Nov 19 ARQT Bears are Losing Control Over Arcutis Biotherapeutics (ARQT), Here's Why It's a 'Buy' Now
        Nov 19 ARQT Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 20-Day Moving Average
        Nov 18 ARQT Arcutis Biotherapeutics: What Lies Ahead
        Nov 15 ARQT Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
        Nov 15 SPRY Loss-Making ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Expected To Breakeven In The Medium-Term
        Nov 15 FBRX Forte Biosciences GAAP EPS of -$4.54
        Nov 14 FBRX Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
        Related Industries: Biotechnology
        Related Stock Lists: Atopic Dermatitis Atopy Dermatitis Immunology Medicine Allergy Dermatology Eczema Organ Systems Sodium Hypochlorite Washes Allergology Alopecia Areata Anaphylaxis Autoimmune Disease Biopharmaceutical Chronic Urticaria Dermatological Diseases Disease Healing Immunoglobulin E
        Type I Hypersensitivity

        Type I Hypersensitivity is an allergic reaction caused by the body's immune system overreacting to a foreign substance, such as pollen, pet dander, or certain foods. Symptoms of Type I Hypersensitivity can include sneezing, itching, hives, and swelling.

        Browse All Tags